EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure

Stopped Positive FAIR-HF study data are available, this study is identical as EFFICACY-HF. Due to low recruitment in EFFICACY-HF the decision was made to terminate it.

Conditions

• Chronic Heart Failure
• Iron Deficiency
• Iron Deficiency Anemia
• Anaemia

Interventions

• DRUG: Ferinject ® (Ferric carboxymaltose)
• DRUG: Normal saline (0.9%)

Sponsor

Vifor Pharma

Collaborators

• [object Object]